BECOME MEMBER SUPPORT
Year Cancer type Speaker
Lung Cancer Update 19 February 2022
Welcome & Introduction
SURGICAL OUTCOMES FROM THE PHASE 3 CHECKMATE 816 TRIAL
Neoadjuvant Pembrolizumab for Early Stage Non Small Cell Lung Cancer
Video and slides 
CRSF Asco list of publications 
Ongoing studies 